Your browser doesn't support javascript.
loading
The application of impulse oscillation system for the evaluation of treatment effects in patients with COPD.
Mineshita, M; Shikama, Y; Nakajima, H; Nishihira, R; Komatsu, S; Kubota, M; Kobayashi, H; Kokubu, F; Shinkai, M; Kaneko, T; Miyazawa, T.
Affiliation
  • Mineshita M; Division of Respiratory and Infectious Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki 216-8511, Japan. Electronic address: m-mine@marianna-u.ac.jp.
  • Shikama Y; Respiratory Disease Center, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-chuo, Tuzuki-ku, Yokohama, Japan. Electronic address: shikamay@med.showa-u.ac.jp.
  • Nakajima H; Respiratory Disease Center, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-chuo, Tuzuki-ku, Yokohama, Japan. Electronic address: hiroaki@med.showa-u.ac.jp.
  • Nishihira R; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama 236-0051, Japan. Electronic address: nishihira@kanagawa-junko.jp.
  • Komatsu S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama 236-0051, Japan. Electronic address: komatsu-s@kanagawa-junko.jp.
  • Kubota M; Respiratory Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara 228-8555, Japan. Electronic address: mkubota@med.kitasato-u.ac.jp.
  • Kobayashi H; Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara 228-8555, Japan. Electronic address: hiro@kitasato-u.ac.jp.
  • Kokubu F; Department of Respiratory Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan. Electronic address: fkokubu@med.showa-u.ac.jp.
  • Shinkai M; Respiratory Disease Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan. Electronic address: shinkai@yokohama-cu.ac.jp.
  • Kaneko T; Respiratory Disease Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan. Electronic address: takeshi@med.yokohama-cu.ac.jp.
  • Miyazawa T; Division of Respiratory and Infectious Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki 216-8511, Japan.
Respir Physiol Neurobiol ; 202: 1-5, 2014 Oct 01.
Article in En | MEDLINE | ID: mdl-25046279
ABSTRACT
There are only a few reports of the use of impulse oscillation system (IOS) for the evaluation of COPD treatment. In this study, we applied IOS and spirometry to evaluate the effectiveness of fluticasone propionate and salmeterol (SFC) combined with tiotropium (TIO) in COPD patients. Following a 4-week run-in period with TIO (18 µg once daily) treatment, COPD patients were randomized to SFC (250/50 µg twice daily; SFC+TIO group, n=25), or TIO alone (TIO group, n=31). Pulmonary functions were recorded by IOS and spirometry before and after the study period. The SFC+TIO group showed significant improvements in inspiratory resistance at 5 Hz and resonant frequency, as well as in FVC and FEV1, after the 12-week treatment (p<0.05). Since there were no significant correlations between improvements in IOS measurements and FVC or FEV1, IOS may provide a physiological point of view that is different from spirometry and seemed to be applicable as an additional assessment tool targeting COPD patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scopolamine Derivatives / Bronchodilator Agents / Outcome Assessment, Health Care / Pulmonary Disease, Chronic Obstructive / Albuterol Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Respir Physiol Neurobiol Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scopolamine Derivatives / Bronchodilator Agents / Outcome Assessment, Health Care / Pulmonary Disease, Chronic Obstructive / Albuterol Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Respir Physiol Neurobiol Year: 2014 Document type: Article